12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2022-08-17), Bristol-Myers Squibb Co's 12-1 Month Momentum % is 10.15%.
The industry rank for Bristol-Myers Squibb Co's 12-1 Month Momentum % or its related term are showing as below:
BMY's 12-1 Month Momentum % is ranked better than 84.22% of 1122
companies
in the Drug Manufacturers industry
Industry Median: -26.00
vs BMY: 10.15
Competitive Comparison
For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bristol-Myers Squibb Co 12-1 Month Momentum % Distribution
For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Bristol-Myers Squibb Co's 12-1 Month Momentum % falls into.
Bristol-Myers Squibb Co (NYSE:BMY) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bristol-Myers Squibb Co (NYSE:BMY) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Bristol-Myers Squibb Co 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.4(0.54%) Volume: 9,008,868 11:08PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:BMY has been successfully added to your 
